Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Icatibant, ATC B06AC02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 261 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Icatibant, ATC B06AC02

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

30 / 100

Risk factors

No estimated value or maximum framework value provided; potential volume of rebates unknown.

Contract may be automatically terminated if another rebate contract for Icatibant is concluded; uncertainty.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Non-exclusive rebate agreements for the active ingredient Icatibant (ATC B06AC02) under §130a Abs. 8 SGB V.
  • Agreements are identical and non-negotiable; all qualified pharmaceutical companies can participate.
Show full summary

AOK Bayern is conducting an open-house model for non-exclusive rebate agreements on the active ingredient Icatibant (ATC B06AC02) under §130a Abs. 8 SGB V. This is not a formal procurement procedure; any interested pharmaceutical company meeting eligibility criteria can conclude an identical, non-negotiable rebate agreement. The contract runs from 01.07.2025 to 30.06.2027, with possible termination on one month's notice. Agreements can be concluded at any time during the period, but no later than 05.05.2027. Submission requires a signed self-declaration of reliability and the signed contract, either in paper form (hand-signed, two copies) or electronically with a qualified electronic signature via the DTVP portal. Only pharmaceutical companies are eligible. Estimated value is not provided.

Risks

No estimated value or maximum framework value provided; potential volume of rebates unknown.

Contract may be automatically terminated if another rebate contract for Icatibant is concluded; uncertainty.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submission of a signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submission of the signed contract including the appendix 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Icatibant, ATC B06AC02

Non-exclusive rebate agreements for the active ingredient Icatibant (ATC B06AC02) with AOK Bayern. Open to all interested pharmaceutical companies that meet the eligibility criteria. Identical, non-negotiable terms. Contract duration: 01.07.2025 to 30.06.2027.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Deadline

Deadline May 05, 2027

Procurement Details

Publication date
15 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
317628-2025

Documents (2)

Similar tenders